Liver Transplant For Budd-Chiari Syndrome Caused by Paroxysmal Nocturnal Hemoglobinuria

dc.contributor.authorYedibela, Süleyman
dc.contributor.authorHohenberger, Werner
dc.date.accessioned2025-11-24T09:23:01Z
dc.date.issued2008-09
dc.description.abstractObjectives: Paroxysmal nocturnal hemoglobinuria is a rare acquired nocturnal disorder of the hematopoietic stem cells. The major causes of associated morbidity and mortality are chronic intravascular hemolysis, pancytopenia, and venous thrombosis. Patients: We report on a 20-year-old man with advanced Budd-Chiari syndrome caused by paroxysmal nocturnal hemoglobinuria, who under­went an emergency liver transplant. Results: At the time of this writing, the patient has good primary hepatic function, and, although not receiving specific medication, shows no signs of pancytopenia. Anticoagulation with low-dose acetylsalicylic acid was initiated. Forty-eight months after the transplant, there are no signs of thromboembolic complications affecting the liver. Conclusions: Liver transplant is an appropriate treatment for Budd-Chiari syndrome caused by paroxysmal nocturnal hemoglobinuria. Sup­plemented by long-term low-dose anticoagulation treatment, liver transplant is superior to other surgical options, particularly when liver disease is advanced.
dc.identifier.eissn2146-8427en
dc.identifier.issn1304-0855
dc.identifier.issue3en
dc.identifier.urihttps://hdl.handle.net/11727/13958
dc.identifier.volume6en
dc.language.isoen_US
dc.publisherBaşkent Üniversitesi
dc.sourceExperimental and Clinical Transplantationen
dc.subjectParoxysmal nocturnal hemoglobinuria
dc.subjectBudd-Chiari syndrome
dc.subjectLiver transplant
dc.titleLiver Transplant For Budd-Chiari Syndrome Caused by Paroxysmal Nocturnal Hemoglobinuria
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
180.pdf
Size:
129.06 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: